Ginkgo Bioworks Holdings, Inc. - stock earnings
DNA Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 9, 2024 AfterMarket | - / -0.0842000000 | - | - / 46.5 million | - |
DNA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -211.7 million USD | 34.8 million USD |
| 2023Q3 | -302.9 million USD | 55.4 million USD |
| 2023Q2 | -173.3 million USD | 80.6 million USD |
| 2023Q1 | -205.0 million USD | 80.7 million USD |
| 2022Q4 | -174.2 million USD | 98.3 million USD |
| 2022Q3 | -669.1 million USD | 66.4 million USD |
| 2022Q2 | -670.6 million USD | 144.6 million USD |
| 2022Q1 | -592.6 million USD | 168.4 million USD |
| 2021Q4 | -1.6 billion USD | 148.5 million USD |
| 2021Q3 | -101.9 million USD | 77.6 million USD |
| 2021Q2 | -53.9 million USD | 43.6 million USD |
| 2021Q1 | -73.6 million USD | 44.1 million USD |
| 2020Q4 | -46.9 million USD | 32.1 million USD |
| 2020Q3 | -26.1 million USD | 13.3 million USD |
DNA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -892.9 million USD | 251.5 million USD |
| 2022 | -2.1 billion USD | 98.3 million USD |
| 2021 | -1.8 billion USD | 313.8 million USD |
| 2020 | -126.7 million USD | 76.7 million USD |
| 2019 | -119.9 million USD | 54.2 million USD |
DNA
Price: $0.89
52 week price:
Earnings Per Share: -0.46 USD
P/E Ratio: -3.68
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Volume: 21.0 million
Market Capitalization: 2.0 billion